Healthcare - Sector
NBIX is currently covered by 21 analysts with an average price target of $193.21. This is a potential upside of $36.62 (23.39%) from yesterday's end of day stock price of $156.59.
Neurocrine Biosciences's activity chart (see below) currently has 849 price targets and 601 ratings on display. The stock rating distribution of NBIX is 82.09% BUY and 17.91% HOLD.
Analysts' price targets on this stock were met 82.41% of the time, taking 318.59 days on average.
Highest price target for NBIX is $253, Lowest price target is $140, average price target is $193.21.
Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 12-Nov-2026. First documented stock forecast 15-Dec-2014.
Currently out of the existing stock ratings of NBIX, 12 are a HOLD (17.91%), 55 are a BUY (82.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Apr-2026
$191
$21.6 (12.75%)
$185
7 days ago
(12-Nov-2026)
30/36 (83.33%)
$21.6 (12.75%)
439
Buy Since 13-Oct-2024
$215
$45.6 (26.92%)
$210
17 days ago
(02-Nov-2026)
24/27 (88.89%)
$69.65 (47.92%)
388
Buy Since 05-May-2025
$190
$20.6 (12.16%)
$198
17 days ago
(02-Nov-2026)
43/47 (91.49%)
$44.65 (30.72%)
153
Buy Since 01-Aug-2023
$220
$50.6 (29.87%)
$200
17 days ago
(02-Nov-2026)
20/22 (90.91%)
$74.65 (51.36%)
398
Buy Since 05-May-2025
$204
$34.6 (20.43%)
$204
1 months 4 days ago
(15-Oct-2026)
6/8 (75%)
$68.29 (50.32%)
181
What is NBIX (Neurocrine Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on NBIX (Neurocrine Biosciences)?
Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?